Related Experiment Videos

Changes in kappa opioid receptor expression during maturation of mouse lymphocytes

T A Ignatowski¹, J M Bidlack

¹Department of Pharmacology and Physiology, University of Rochester, School of Medicine and Dentistry, New York 14642-8711, USA.

Advances in Experimental Medicine and Biology

|July 17, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2015

Extracellular biotransformation of beta-endorphin in rat striatum and cerebrospinal fluid.

Journal of neuroendocrinology·2008

An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.

Neuroscience·2005

Delta opioid antagonist effects of buprenorphine in rhesus monkeys.

Behavioural pharmacology·2002

Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan.

Bioorganic & medicinal chemistry letters·2001

Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence.

International immunopharmacology·2001

See all related articles